Subramanian Rajagopalan

Subramanian Rajagopalan

Buck Institute for Research on Aging - Novato / United States
Medical and Health Sciences / Neuroscience
AD Scientific Index ID: 4473545
person_outline Subramanian Rajagopalan's MOST POPULAR ARTICLES
1-) Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'s diseaseD Kaur, F Yantiri, S Rajagopalan, J Kumar, JQ Mo, R Boonplueang, ...Neuron 37 (6), 899-909, 20037212003
2-) Glutathione, iron and Parkinson’s diseaseS Bharath, M Hsu, D Kaur, S Rajagopalan, JK AndersenBiochemical pharmacology 64 (5-6), 1037-1048, 20025162002
3-) Cellular senescence is induced by the environmental neurotoxin paraquat and contributes to neuropathology linked to Parkinson’s diseaseSJ Chinta, G Woods, M Demaria, A Rane, Y Zou, A McQuade, ...Cell reports 22 (4), 930-940, 20182902018
4-) MAO-B elevation in mouse brain astrocytes results in Parkinson\'s pathologyJK Mallajosyula, D Kaur, SJ Chinta, S Rajagopalan, A Rane, DG Nicholls, ...PloS one 3 (2), e1616, 20083032008
5-) Increased murine neonatal iron intake results in Parkinson-like neurodegeneration with ageD Kaur, J Peng, SJ Chinta, S Rajagopalan, DA Di Monte, RA Cherny, ...Neurobiology of aging 28 (6), 907-913, 20071772007